NCT Number: NCT02259244
Effect of Mediterranean and Hypolipemic Reduction Diet in Obese Patients
The purpose of this study is to evaluate the combined effect of physical activity and adherence to Mediterranean diet or Hypolipemic Reduction diet on parameters of oxidative stress in obese patients enrolled in the weight management reduction program.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–69 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- BMI ≥ 30 kg/m2
Exclusion criteria
- newly diagnosed diabetes, hypertension or cardiovascular disease
- change in antihypertensive therapy and antidiabetic therapy in the period of 3 months prior to the commencement of the study
- insulin therapy
- alcohol consumption >500 g of alcohol/week in the last year
- pregnancy or breast feeding
- use of drugs affecting weight control (eg. weight loss medication or systemic glucocorticoids)
Treatment and study plan
Primary outcomes
-
Oxidative stress
Time frame: The outcome measure is studied at baseline, 1 and 12 months
Secondary outcomes
-
Body weight (kg)
Time frame: The outcome measure is studied at baseline, 1 week, 1 month, 3, 6 and 12 months
-
Waist circumference (cm)
Time frame: The outcome measure is studied at baseline, 1 week, 1 month, 3, 6 and 12 months
-
Fasting glycemia
Time frame: The outcome measure is studied at baseline, 1 week, 1 month, 3, 6 and 12 months
-
Lipid profile (HLD, LDL, TC,)
Time frame: The outcome measure is studied at baseline, 1 week, 1 month, 3, 6 and 12 months
-
Urate
Time frame: The outcome measure is studied at baseline, at 1 week, 1 month, 3, 6 and 12 months
-
Blood pressure (mmHg)
Time frame: The outcome measure is studied at baseline, at 1 week, 1 month, 3, 6 and 12 months
-
Physical activity level
Time frame: The outcome measure is studied at baseline, at 1 month, 3, 6 and 12 months
IPAQ-SF for record on physical activity during 7 last 7 days.
-
Quality of life
Time frame: The outcome measure is studied at baseline, at 1 month, 3, 6 and 12 months
SF-36 questionnaire
-
Dietary intakes
Time frame: The outcome measure is studied at baseline, at 1 month, 3, 6 and 12 months
Food Frequency Questionnaire 7-day food diary
Sponsors and collaborators
Lead sponsor
University of Zagreb
Other
Collaborators
- University Hospital Dubrava
Registry information
Official study title
Effect of the Mediterranean Diet and Hypolipemic Reduction Diet in Combination With Exercise in Obese Croatian Population- 1-year Randomized Controlled Trial
Important dates
- Study start
- 2008
- Primary completion
- 2013
- Study completion
- 2013
- First posted
- Oct 8, 2014
- Registry last updated
- Oct 8, 2014
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Time Restricted Eating for Weight Loss Maintenance
NCT05742165
Behavior, Body Weight
New York, United States
View Trial DetailsA Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
NCT05882045
Body Weight, Cardiovascular Diseases
Phoenix, Arizona, United States
View Trial DetailsA Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight
NCT05929079
Apnea, Body Weight
Anniston, Alabama, United States
View Trial DetailsThe Food Intake Phenotype: Assessing Eating Behavior and Food Preferences as Risk Factors for Obesity
NCT00342732
Body Weight, Nutrition Disorders
Phoenix, Arizona, United States
View Trial Details